While the vast majority of autosomal genes are expressed from both parental alleles, a small subset of genes, most of which are involved with development, growth and behavior, are expressed from only one allele. These genes are said to be imprinted, as it was initially hypothesized that an epigenetic mark was present on one of the alleles to prevent its transcription. Mutations in imprinted genes are responsible for a number of diseases, including Prader-Willi Syndrome and pseudohypoparathyroidism. The goal of this grant is to discover and explain the underlying mechanisms governing the imprinting of genes. Two specific areas are targeted for intense investigation: 1. Deciphering the Histone Code: It has recently been shown that histones may be modified by acetylation, methylation, phosphorylation, and ubiquitination, and that these modifications may regulate gene transcription. These studies will determine if there is a specific or characteristic histone code that signals to the cell's transcriptional machinery that a gene is imprinted and that only one of the alleles should be transcribed. 2. The Epigenome in Cancer and Development: DNA methylation has been shown to be an important component of the imprinting process, as differentially methylated regions are often associated with gene silencing. Using a novel methylated oligonucleotide approach, it will be possible to add methyl groups to a specific region of a gene and thereby induce specific DNA methylation changes to learn how region-specific methylation can alter the imprinting process. The role of methylation patterns in imprinted genes that have lost imprinting in malignant tissues will also be examined. These aspects of the control of genomic imprinting are closely inter-related and inter-dependent phenomena, and advances in one area will provide new insights into the other mechanisms governing transcriptional control. Ultimately, it will be possible to develop a comprehensive chromatin/DNA model of imprinting. ? ?

Agency
National Institute of Health (NIH)
Institute
National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK)
Type
Research Project (R01)
Project #
3R01DK036054-14S1
Application #
7114245
Study Section
Mammalian Genetics Study Section (MGN)
Program Officer
Sato, Sheryl M
Project Start
1986-07-01
Project End
2008-03-31
Budget Start
2005-04-01
Budget End
2006-03-31
Support Year
14
Fiscal Year
2005
Total Cost
$50,263
Indirect Cost
Name
Stanford University
Department
Internal Medicine/Medicine
Type
Schools of Medicine
DUNS #
009214214
City
Stanford
State
CA
Country
United States
Zip Code
94305
Li, Tao; Hu, Ji-Fan; Qiu, Xinwen et al. (2008) CTCF regulates allelic expression of Igf2 by orchestrating a promoter-polycomb repressive complex 2 intrachromosomal loop. Mol Cell Biol 28:6473-82
Qiu, Xinwen; Vu, Thanh H; Lu, Qiucheng et al. (2008) A complex deoxyribonucleic acid looping configuration associated with the silencing of the maternal Igf2 allele. Mol Endocrinol 22:1476-88
Chen, Theresa L; Shen, Wen-Jun; Qiu, Xin-Wen et al. (2007) Generation of novel adipocyte monolayer cultures from embryonic stem cells. Stem Cells Dev 16:371-80
Ling, Jian Qun; Hoffman, Andrew R (2007) Epigenetics of long-range chromatin interactions. Pediatr Res 61:11R-16R
Hoffman, Andrew R; Hu, Ji Fan (2006) Directing DNA methylation to inhibit gene expression. Cell Mol Neurobiol 26:425-38
Chen, Hui Ling; Li, Tao; Qiu, Xin Wen et al. (2006) Correction of aberrant imprinting of IGF2 in human tumors by nuclear transfer-induced epigenetic reprogramming. EMBO J 25:5329-38
Ling, Jian Qun; Li, Tao; Hu, Ji Fan et al. (2006) CTCF mediates interchromosomal colocalization between Igf2/H19 and Wsb1/Nf1. Science 312:269-72
Li, Tao; Vu, Thanh H; Ulaner, Gary A et al. (2005) IVF results in de novo DNA methylation and histone methylation at an Igf2-H19 imprinting epigenetic switch. Mol Hum Reprod 11:631-40
Vu, Thanh H; Li, Tao; Hoffman, Andrew R (2004) Promoter-restricted histone code, not the differentially methylated DNA regions or antisense transcripts, marks the imprinting status of IGF2R in human and mouse. Hum Mol Genet 13:2233-45
Vu, Thanh H; Chuyen, Nguyen V; Li, Tao et al. (2003) Loss of imprinting of IGF2 sense and antisense transcripts in Wilms' tumor. Cancer Res 63:1900-5

Showing the most recent 10 out of 87 publications